Northern Trust’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,019,087
| Closed | -$73.5M | – | 4513 |
|
|
2025
Q4 | $73.5M | Buy |
1,019,087
+44,031
| +5% | +$2.84M | 0.01% | 889 |
|
|
2025
Q3 | $42.5M | Sell |
975,056
-21,999
| -2% | -$889K | 0.01% | 1232 |
|
|
2025
Q2 | $28.3M | Sell |
997,055
-21,427
| -2% | -$639K | ﹤0.01% | 1441 |
|
|
2025
Q1 | $30.1M | Sell |
1,018,482
-60,952
| -6% | -$1.9M | ﹤0.01% | 1391 |
|
|
2024
Q4 | $31.4M | Buy |
1,079,434
+108,303
| +11% | +$4.53M | ﹤0.01% | 1422 |
|
|
2024
Q3 | $44.6M | Buy |
971,131
+211,059
| +28% | +$9.16M | 0.01% | 1102 |
|
|
2024
Q2 | $31M | Buy |
760,072
+88,744
| +13% | +$2.55M | 0.01% | 1278 |
|
|
2024
Q1 | $17.1M | Buy |
671,328
+8,460
| +1% | +$133K | ﹤0.01% | 1691 |
|
|
2023
Q4 | $6M | Buy |
662,868
+22,524
| +4% | +$151K | ﹤0.01% | 2391 |
|
|
2023
Q3 | $4.09M | Sell |
640,344
-11,156
| -2% | -$96.1K | ﹤0.01% | 2565 |
|
|
2023
Q2 | $7.23M | Buy |
651,500
+50,093
| +8% | +$628K | ﹤0.01% | 2278 |
|
|
2023
Q1 | $9.23M | Buy |
601,407
+73,552
| +14% | +$1.62M | ﹤0.01% | 2070 |
|
|
2022
Q4 | $11.7M | Buy |
527,855
+46,947
| +10% | +$700K | ﹤0.01% | 1895 |
|
|
2022
Q3 | $7.85M | Buy |
480,908
+23,994
| +5% | +$459K | ﹤0.01% | 2161 |
|
|
2022
Q2 | $6.64M | Buy |
456,914
+83,520
| +22% | +$1.24M | ﹤0.01% | 2322 |
|
|
2022
Q1 | $6.9M | Sell |
373,394
-5,847
| -2% | -$99.3K | ﹤0.01% | 2381 |
|
|
2021
Q4 | $9.01M | Buy |
379,241
+24,011
| +7% | +$573K | ﹤0.01% | 2308 |
|
|
2021
Q3 | $8.75M | Buy |
355,230
+83,960
| +31% | +$1.82M | ﹤0.01% | 2376 |
|
|
2021
Q2 | $6.7M | Sell |
271,270
-16,409
| -6% | -$382K | ﹤0.01% | 2647 |
|
|
2021
Q1 | $6.27M | Buy |
287,679
+95,456
| +50% | +$2.34M | ﹤0.01% | 2605 |
|
|
2020
Q4 | $4.91M | Sell |
192,223
-1,204
| -0.6% | -$35.1K | ﹤0.01% | 2693 |
|
|
2020
Q3 | $5.45M | Buy |
+193,427
| New | +$5.59M | ﹤0.01% | 2488 |
|
Other funds holding RNAM
Northern Trust's RNAM Position: Q1 2026 in Review
Northern Trust sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,019,087 shares — an estimated $73.5M sold.
Northern Trust first reported a position in RNAM in Q3 2020 and held it in 22 quarters. The position peaked at $73.5M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Northern Trust reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 1,019,087 Avidity Biosciences shares in Q1 2026, an estimated $73.5M.
- Northern Trust first reported a position in Avidity Biosciences in Q3 2020 and held it in 22 quarters.
- Northern Trust's Avidity Biosciences position peaked at $73.5M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.